WebAug 28, 2024 · TTK is overexpressed in multiple cancers and the biomarker is associated with worse prognosis. With CFI-402257, Treadwell is specifically hoping to target TTK in estrogen receptor-positive, HER2-negative breast cancer patients who need new treatment options after they become resistant to CDK4/6 inhibitors. WebFeb 25, 2024 · Cancer-testis antigens (CTAs) are often expressed in tumor and testicular tissues but not in other normal tissues. To date, there has been no comprehensive study of the expression and clinical significance of CTA genes associated with endometrial cancer (EC) development. Additionally, the clinical relevance, biological role, and molecular …
TTK Inhibitors as a Targeted Therapy for - PubMed
WebMutations in CTNNB1 occur at relatively high frequency in endometrial cancer and hepatocellular carcinoma, which are known to express high TTK levels. We propose … WebNov 1, 2024 · Abstract. The spindle assembly checkpoint kinase TTK (Mps1) is a key regulator of chromosome segregation and is the subject of novel targeted therapy approaches by small-molecule inhibitors. Although the first TTK inhibitors have entered phase I dose escalating studies in combination with taxane chemotherapy, a patient … billy x dot
Expression of TTK in cancer - Summary - The Human Protein Atlas
WebApr 23, 2024 · TTK inhibitor AZ3146 could simulated liver cancer cells to accumulate in the G2/M phase, which ultimately enhances DNA damage with more γ-H2AX foci and more … WebMay 20, 2013 · Triple-negative breast cancer (TNBC) represents a subgroup of breast cancers (BC) associated with the most aggressive clinical behavior. No targeted therapy is currently available for the treatment of patients with TNBC. In order to discover potential therapeutic targets, we searched for protein kinases that are overexpressed in human … WebAug 1, 2015 · TTK inhibitors are anticipated to be more active in SAC dependent tumors and data in the literature suggests that triple negative breast cancer is among the tumor types potentially highly dependent on TTK activity. Moreover, in accelerating mitosis, TTK inhibitors have a novel mode of action as compared to currently known mitotic inhibitors. cynthia lin scratch island strum